Navigation Links
Optimal Warfarin Dosing Improves Anticoagulation Control
Date:12/30/2008

Increasing time within the therapeutic range of utmost importance, study finds

TUESDAY, Dec. 30 (HealthDay News) -- While the anticoagulant warfarin can be highly effective in preventing strokes and treating venous thromboembolism, doctors have long struggled with finding the best way manage the drug therapy.

Boston University School of Medicine (BUSM) researchers now claim to have figured out the optimal dosing levels to help patients, according to a study published in December online issue of the Journal of Thrombosis and Haemostasis.

The research team analyzed warfarin use in almost 4,000 patients to determine what are the most effective levels of the drug in a patient's system under different circumstances.

"The study suggests that anticoagulation control could be improved considerably by changing the warfarin dose only when the ratio is 1.7 or lower/3.3 or higher," lead author Dr. Adam Rose, an assistant professor of medicine at BUSM, said in a university news release. "In addition to offering warfarin to as many optimal candidates as possible, we also need to optimize warfarin dose management to fully realize the benefits of anticoagulation."

Previous studies have found that doctors often do not prescribe warfarin enough or at less than optimal doses for patients who could most benefit from it. Part of the reason is not enough is known about proper dosing levels, and misuse of warfarin can put patients at a higher risk of stroke, bleeding and other medical complications.

"This lack of evidence regarding optimal management strategies probably contributes to our limited success in maintaining patients within the therapeutic range," said Rose, who is also a core investigator in the Center for Health Quality, Outcomes and Economic Research at Bedford VA Medical Center in Massachusetts. "Previous studies have clearly shown that time spent outside the therapeutic range contributes to more adverse events for patients, such as stroke and gastrointestinal hemorrhage. Therefore, increasing the time in the therapeutic range is of utmost importance."

More information

The U.S. National Library of Medicine has more about warfarin.



-- Kevin McKeever



SOURCE: Boston University School of Medicine, news release, Dec. 22, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study shows optimal dose management of warfarin improves anticoagulation control
2. Doctors Receive Bonuses for Providing Optimal Care to Patients Through Bridges to Excellence
3. Penn scientists show how body determines optimal amount of germ-fighting B cells
4. New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery
5. Statement on CDC Announcement That 70 Percent of the U. S. Population Now Receives Optimally Fluoridated Water By Mark J. Feldman, DMD, President, American Dental Association
6. High-Performing Sales Forces Share Key Practices to Achieve Optimal Performance
7. eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results
8. Medco, Healthways Launch Center for Health Action to Deliver Optimal Health(TM)
9. Optimal Readings Selected to Present at CEDs 25th Annual Venture Conference
10. Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations
11. Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Optimal Warfarin Dosing Improves Anticoagulation Control
(Date:2/9/2016)... ... February 09, 2016 , ... ... LLC to help enterprises move workloads to the cloud. Cirracore provides a ... their cloud without traversing the Internet. Transformation Solutions (TSL Partners) provides a ...
(Date:2/9/2016)... New York, NY (PRWEB) , ... February 09, 2016 , ... ... announce the appointment of Dr. David Hung to the company´s Board of Directors. ... is a world class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton ... and Younkers department stores, announced it has raised $176,000 to benefit the Breast ... Comprehensive Cancer Center at the University of Iowa, The Lynn Sage Cancer Research ...
(Date:2/9/2016)... ... February 09, 2016 , ... METTLER ... ensure lab personnel have a basic understanding of the techniques they use so ... understanding will help them reduce waste and rework to create a leaner overall ...
(Date:2/9/2016)... ... 09, 2016 , ... United Methodist Communications collaborated with Chocolate ... animated video designed to prevent the next widespread Ebola outbreak from ... being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Feb. 9, 2016  Landauer, Inc. (NYSE: LDR ... measurement and monitoring, outsourced medical physics services and high ... its fiscal 2016 first quarter ended December 31, 2015. ... Fiscal 2016 First Quarter Highlights , Revenue of ... quarter of 2015 , Domestic Radiation Measurement services revenues ...
(Date:2/9/2016)... , February 9, 2016 ... QIA) gab heute den Abschluss eines Kooperationsvertrags ... Förderung umfassender Lösungen in den Bereichen Next-Generation-Sequencing ... QGEN ; Frankfurt Prime Standard: QIA) ... 10x Genomics für die Entwicklung und Förderung ...
(Date:2/9/2016)... Feb. 9, 2016 Mast Therapeutics, Inc. ... for sickle cell disease and heart failure, today announced that ... to purchase common stock in an underwritten public offering.  The ... can be no assurance as to whether or when the ... or terms of the offering.   --> ...
Breaking Medicine Technology: